Practical considerations on the introduction of sacubitril/valsartan in clinical practice: Current evidence and early experience
D Farmakis, V Bistola, A Karavidas, J Parissis - International Journal of …, 2016 - Elsevier
The combination of neprilysin inhibitor sacubitril with the angiotensin II receptor 1 blocker
valsartan is the first agent from the angiotensin receptor neprilysin inhibitors (ARNI) class …
valsartan is the first agent from the angiotensin receptor neprilysin inhibitors (ARNI) class …
Practical considerations on the introduction of sacubitril/valsartan in clinical practice: Current evidence and early experience
D Farmakis, V Bistola, A Karavidas… - International Journal of …, 2016 - infona.pl
The combination of neprilysin inhibitor sacubitril with the angiotensin II receptor 1 blocker
valsartan is the first agent from the angiotensin receptor neprilysin inhibitors (ARNI) class …
valsartan is the first agent from the angiotensin receptor neprilysin inhibitors (ARNI) class …
Practical considerations on the introduction of sacubitril/valsartan in clinical practice: Current evidence and early experience
D Farmakis, V Bistola… - … journal of cardiology, 2016 - pubmed.ncbi.nlm.nih.gov
The combination of neprilysin inhibitor sacubitril with the angiotensin II receptor 1 blocker
valsartan is the first agent from the angiotensin receptor neprilysin inhibitors (ARNI) class …
valsartan is the first agent from the angiotensin receptor neprilysin inhibitors (ARNI) class …
Practical considerations on the introduction of sacubitril/valsartan in clinical practice: Current evidence and early experience
D Farmakis, V Bistola… - International …, 2016 - internationaljournalofcardiology.com
The combination of neprilysin inhibitor sacubitril with the angiotensin II receptor 1 blocker
valsartan is the first agent from the angiotensin receptor neprilysin inhibitors (ARNI) class …
valsartan is the first agent from the angiotensin receptor neprilysin inhibitors (ARNI) class …
Practical considerations on the introduction of sacubitril/valsartan in clinical practice: Current evidence and early experience.
D Farmakis, V Bistola, A Karavidas… - International Journal of …, 2016 - europepmc.org
The combination of neprilysin inhibitor sacubitril with the angiotensin II receptor 1 blocker
valsartan is the first agent from the angiotensin receptor neprilysin inhibitors (ARNI) class …
valsartan is the first agent from the angiotensin receptor neprilysin inhibitors (ARNI) class …